Showing results (561-570 of 762) with videos related to
Sort By:
Pageof 77
Reviews on Recent Clinical Trials|March 31, 2026
Leqembi (Lecanemab) in Early Alzheimer's Disease: A Review of Clinical Trial Evidence and Therapeutic ImplicationsAndrew Ashchi, Andrea Ashchi Lachapelle, Selim Nassirou, et al.Reviews on Recent Clinical Trials|April 13, 2026
Efficacy and Safety of Bumetanide in Children with Autism Spectrum Disorder: A Systematic Review and Meta-AnalysisAusaf Ur Rehman, Aakriti Garg, Mohd Ashif KhanReviews on Recent Clinical Trials|April 13, 2026
Teeth Health in Patients with Diabetes or Cardiovascular Disease: A Current and Updated ReviewPardis Palizban, Zahra Tolou-GhamariReviews on Recent Clinical Trials|April 13, 2026
Immunotherapeutics in Combination with Chemotherapy in Clinical TrialsRahaman Shaik, M Shaheer Malik, Munirah M Al-Rooqi, et al.Reviews on Recent Clinical Trials|June 17, 2026
Guar Gum, Partially Hydrolyzed Guar Gum, and Human Gut Health: A Narrative ReviewEmidio Scarpellini, Francesca Roselli, Marialaura Scarcella, et al.Reviews on Recent Clinical Trials|June 8, 2026
Applications of Artificial Intelligence and Machine Learning in Drug DeliveryAshish Kumar Parashar, Vandana Arora Sethi, Gaurav Kant Saraogi, et al.Reviews on Recent Clinical Trials|July 20, 2026
Genotoxicity and Proteotoxicity of Arsenic: Mechanisms, Clinical Implications, and Therapeutic ChallengesPawan Kumar Goswami, Siddhant Krishna, Qumar Negar, et al.Reviews on Recent Clinical Trials|July 23, 2026
Genomic Characterization of Hospital-acquired Methicillin-resistant Staphylococcus aureus (MRSA) based on Whole Genome Sequencing in Ramadi City HospitalAwad Mohammed Hammed, Laith Muslih Najeeb, Safaa Abed Latef AlmeaniReviews on Recent Clinical Trials|August 11, 2026
Hydrogel-forming Microneedles for Multi-drug and Phytochemical Co-delivery: Translational Opportunities in Autoimmune and Inflammatory DisordersD Ezhilarasi, Rajaganapathy KaliyaperumalReviews on Recent Clinical Trials|May 21, 2010
The pathogenesis, complications and therapeutic strategy for hepatitis C virus-associated insulin resistance in the era of anti-viral treatmentTakumi Kawaguchi, Eitaro Taniguchi, Minoru Itou, et al.Pageof 77